colorectal cancer
Showing NaN - NaN of 125
Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +19 more
- A2B694
- xT CDx with HLA-LOH Assay
-
Duarte, California
- +9 more
Sep 22, 2023
Colorectal Cancer, Healthy Lifestyle, Behavior, Health Trial in Los Angeles (RISE Personalized Self-Managament Training (PSMT),
Not yet recruiting
- Colorectal Cancer
- +3 more
- RISE Personalized Self-Managament Training (PSMT)
- Standardized Self-Managament Training (SSMT)
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Aug 2, 2023
Advanced Solid Tumor, Colorectal Cancer Trial in Los Angeles (TORL-3-600)
Not yet recruiting
- Advanced Solid Tumor
- Colorectal Cancer
-
Los Angeles, CaliforniaUCLA - JCCC Clinical Research Unit
Jul 20, 2023
Colorectal Cancer, Type 2 Diabetes Trial in Los Angeles (Intervention Group (IG))
Not yet recruiting
- Colorectal Cancer
- Type 2 Diabetes
- Intervention Group (IG)
-
Los Angeles, CaliforniaCharles R. Drew University
Mar 10, 2023
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
Colorectal Cancer Screening in Cystic Fibrosis
Recruiting
- Cystic Fibrosis
- +2 more
- Stool tests
-
Los Angeles, California
- +24 more
Jan 26, 2023
Colorectal Cancer, Metastatic Colorectal Cancer Trial in United States (Onvansertib, FOLFIRI, Bevacizumab)
Recruiting
- Colorectal Cancer
- Metastatic Colorectal Cancer
- Onvansertib
- +2 more
-
Birmingham, Alabama
- +38 more
Jan 25, 2023
Cutaneous Melanoma, Pleural Mesothelioma, HER2 Negative Breast Tumors Trial in Worldwide (SGN-CD228A)
Active, not recruiting
- Cutaneous Melanoma
- +5 more
-
Birmingham, Alabama
- +13 more
Jan 23, 2023
Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)
Recruiting
- Minimal Residual Disease
- +11 more
- ELI-002 2P
-
Duarte, California
- +10 more
Jan 18, 2023
Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer Trial in Huntersville (FT536, Cyclophosphamide, Fludarabine)
Recruiting
- Non Small Cell Lung Cancer
- +6 more
- FT536
- +10 more
-
Scottsdale, Arizona
- +4 more
Dec 27, 2022
Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)
Active, not recruiting
- Melanoma
- +7 more
- Autogene cevumeran
- Atezolizumab
-
Scottsdale, Arizona
- +36 more
Dec 22, 2022
NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in Canada, United States (PF-06946860, Placebo for PF-06946860)
Completed
- Non-small Cell Lung Cancer
- +9 more
- PF-06946860
- Placebo for PF-06946860
-
Little Rock, Arkansas
- +32 more
Dec 12, 2022
Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Virtual group based physical activity (BurnAlong) and Social Media
Recruiting
- Cancer
- +21 more
- Virtual group based physical activity (BurnAlong) and Social Media Discussion Board
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Dec 7, 2022
Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))
Available
- Pancreatic Cancer
- +20 more
- Ulixertinib (BVD-523)
-
Birmingham, Alabama
- +25 more
Nov 4, 2022
Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)
Recruiting
- Solid Tumor
- +11 more
- TRK-950
- +14 more
-
Scottsdale, Arizona
- +13 more
Oct 2, 2022
Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal
Recruiting
- Breast Cancer
- +15 more
- ATRC-101
- +2 more
-
Phoenix, Arizona
- +10 more
Sep 28, 2022
Colorectal Cancer Trial in Worldwide (Obinutuzumab, Atezolizumab, Cibisatamab)
Active, not recruiting
- Colorectal Cancer
- Obinutuzumab
- +3 more
-
Los Angeles, California
- +12 more
Aug 19, 2022
Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)
Active, not recruiting
- Advanced Solid Tumors
- +7 more
- Pembrolizumab
- Lenvatinib
-
Duarte, California
- +87 more
Aug 19, 2022
Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus
Recruiting
- Mesothelioma
- +14 more
- NGM707
- NGM707 plus pembrolizumab
-
Los Angeles, California
- +13 more
Aug 16, 2022
Colorectal Cancer, Colorectal Cancer Metastatic Trial in United States (Pembrolizumab, Regorafenib)
Active, not recruiting
- Colorectal Cancer
- Colorectal Cancer Metastatic
- Pembrolizumab
- Regorafenib
-
Duarte, California
- +3 more
Aug 5, 2022
Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan
Not yet recruiting
- Endometrial Cancer
- +4 more
- Datopotamab deruxtecan (Dato-DXd)
- +8 more
-
Los Angeles, California
- +52 more
Aug 3, 2022
Informed Choice - Compass
Recruiting
- Colorectal Cancer
- Brief Video
- Brief Video Plus
-
Los Angeles, California
- +5 more
Jul 29, 2022